1. Home
  2. JSPRW vs FRES Comparison

JSPRW vs FRES Comparison

Compare JSPRW & FRES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPRW
  • FRES
  • Stock Information
  • Founded
  • JSPRW N/A
  • FRES 2010
  • Country
  • JSPRW United States
  • FRES United States
  • Employees
  • JSPRW 45
  • FRES N/A
  • Industry
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • FRES Medical Specialities
  • Sector
  • JSPRW Health Care
  • FRES Health Care
  • Exchange
  • JSPRW Nasdaq
  • FRES Nasdaq
  • Market Cap
  • JSPRW N/A
  • FRES N/A
  • IPO Year
  • JSPRW 2020
  • FRES 2020
  • Fundamental
  • Price
  • JSPRW $0.22
  • FRES $0.85
  • Analyst Decision
  • JSPRW
  • FRES
  • Analyst Count
  • JSPRW 0
  • FRES 0
  • Target Price
  • JSPRW N/A
  • FRES N/A
  • AVG Volume (30 Days)
  • JSPRW N/A
  • FRES 27.6K
  • Earning Date
  • JSPRW N/A
  • FRES 12-31-2024
  • Dividend Yield
  • JSPRW N/A
  • FRES N/A
  • EPS Growth
  • JSPRW N/A
  • FRES N/A
  • EPS
  • JSPRW N/A
  • FRES N/A
  • Revenue
  • JSPRW N/A
  • FRES $2,341,326.00
  • Revenue This Year
  • JSPRW N/A
  • FRES N/A
  • Revenue Next Year
  • JSPRW N/A
  • FRES N/A
  • P/E Ratio
  • JSPRW N/A
  • FRES N/A
  • Revenue Growth
  • JSPRW N/A
  • FRES 94.50
  • 52 Week Low
  • JSPRW N/A
  • FRES $0.73
  • 52 Week High
  • JSPRW N/A
  • FRES $9.00
  • Technical
  • Relative Strength Index (RSI)
  • JSPRW N/A
  • FRES 33.73
  • Support Level
  • JSPRW N/A
  • FRES $0.73
  • Resistance Level
  • JSPRW N/A
  • FRES $1.47
  • Average True Range (ATR)
  • JSPRW 0.00
  • FRES 0.21
  • MACD
  • JSPRW 0.00
  • FRES -0.03
  • Stochastic Oscillator
  • JSPRW 0.00
  • FRES 15.31

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: